Algoritmos de tratamiento de la colitis ulcerosa desde una experiencia local

Revista Médica Clínica Las Condes - Tập 29 - Trang 570-579 - 2018
Carolina Figueroa1, Jaime Lubascher1, Patricio Ibáñez1, Rodrigo Quera1, Udo Kronberg2, Daniela Simian3, Lilian Flores1
1Departamento de Gastroenterología; Unidad de Coloproctología, Clínica Las Condes, Santiago, Chile
2Departamento de Cirugía, Clínica Las Condes, Santiago, Chile
3Subdirección de Investigación, Dirección Académica, Programa de Enfermedad Inflamatoria Intestinal, Clínica Las Condes, Santiago, Chile

Tài liệu tham khảo

Van Assche, 2010, The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis, J Crohns Colitis, 4, 7, 10.1016/j.crohns.2009.12.003 Langholz, 1994, Course of ulcerative colitis: analysis of changes in disease activity over years, Gastroenterology, 107, 3, 10.1016/0016-5085(94)90054-X Turner, 2007, Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression, Clin Gastroenterol Hepatol, 5, 103, 10.1016/j.cgh.2006.09.033 Christensen, 2017, Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes, Clin Gastroenterol Hepatol, 15, 1557, 10.1016/j.cgh.2017.02.016 Schroeder, 1987, Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study, N Engl J Med, 317, 1625, 10.1056/NEJM198712243172603 Pizarro, 2017, Factores pronósticos en Colitis Ulcerosa de reciente diagnóstico, Rev Med Chile, 145, 1319, 10.4067/S0034-98872017001001319 Chang, 2018, Fecal Immunochemical Test and Fecal Calprotectin Measurement Are Noninvasive Monitoring Tools for Predicting Endoscopic Activity in Patients with Ulcerative Colitis, Gut Liver., 12, 117, 10.5009/gnl17445 Mak WY, Buisson A, Andersen MJ Jr, Lei D, Pekow J, Cohen RD, et al. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis. Dig Dis Sci. 2018 Feb 22. doi: 10.1007/s10620-018-4980-0.[Epub ahead of print]. Duijvestein, 2018, Novel Therapies and Treatment Strategies for Patients with Inflammatory Bowel Disease, Curr Treat Options Gastroenterol, 16, 129, 10.1007/s11938-018-0175-1 Zezos, 2014, Inflammatory bowel disease and thromboembolism, World J Gastroenterol, 20, 13863, 10.3748/wjg.v20.i38.13863 Hindryckx, 2017, Review article: dose optimisation of infliximab for acute severe ulcerative colitis, Aliment Pharmacol Ther, 45, 617, 10.1111/apt.13913